Table of Contents

Executive Summary

1 Industry Overview of Galectin 3

• 1.1 Definition of Galectin 3
• 1.2 Galectin 3 Segment by Type
  • 1.2.1 Global Galectin 3 Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 GAL-300
  • 1.2.3 GRMD-03
  • 1.2.4 ANG-4021
  • 1.2.5 KTI
  • 1.2.6 Others
• 1.3 Galectin 3 Segment by Applications
  • 1.3.1 Global Galectin 3 Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Liver Cirrhosis
  • 1.3.3 Portal Hypertension
  • 1.3.4 Metastatic Melanoma
  • 1.3.5 Others
• 1.4 Global Galectin 3 Overall Market
  • 1.4.1 Global Galectin 3 Revenue (2014-2025)
  • 1.4.2 Global Galectin 3 Production (2014-2025)
  • 1.4.3 North America Galectin 3 Status and Prospect (2014-2025)
  • 1.4.4 Europe Galectin 3 Status and Prospect (2014-2025)
  • 1.4.5 China Galectin 3 Status and Prospect (2014-2025)
  • 1.4.6 Japan Galectin 3 Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Galectin 3 Status and Prospect (2014-2025)
  • 1.4.8 India Galectin 3 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Galectin 3
• 2.3 Manufacturing Process Analysis of Galectin 3
• 2.4 Industry Chain Structure of Galectin 3

3 Development and Manufacturing Plants Analysis of Galectin 3

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Galectin 3 Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Galectin 3
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Galectin 3 Production and Capacity Analysis
• 4.2 Galectin 3 Revenue Analysis
• 4.3 Galectin 3 Price Analysis
• 4.4 Market Concentration Degree

5 Galectin 3 Regional Market Analysis

• 5.1 Galectin 3 Production by Regions
  • 5.1.1 Global Galectin 3 Production by Regions
  • 5.1.2 Global Galectin 3 Revenue by Regions
• 5.2 Galectin 3 Consumption by Regions
• 5.3 North America Galectin 3 Market Analysis
  • 5.3.1 North America Galectin 3 Production
  • 5.3.2 North America Galectin 3 Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Galectin 3 Import and Export
• 5.4 Europe Galectin 3 Market Analysis
  • 5.4.1 Europe Galectin 3 Production
  • 5.4.2 Europe Galectin 3 Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Galectin 3 Import and Export
• 5.5 China Galectin 3 Market Analysis
  • 5.5.1 China Galectin 3 Production
  • 5.5.2 China Galectin 3 Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Galectin 3 Import and Export
• 5.6 Japan Galectin 3 Market Analysis
  • 5.6.1 Japan Galectin 3 Production
  • 5.6.2 Japan Galectin 3 Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Galectin 3 Import and Export
• 5.7 Southeast Asia Galectin 3 Market Analysis
  • 5.7.1 Southeast Asia Galectin 3 Production
  • 5.7.2 Southeast Asia Galectin 3 Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Galectin 3 Import and Export
• 5.8 India Galectin 3 Market Analysis
  • 5.8.1 India Galectin 3 Production
  • 5.8.2 India Galectin 3 Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Galectin 3 Import and Export

6 Galectin 3 Segment Market Analysis (by Type)

• 6.1 Global Galectin 3 Production by Type
• 6.2 Global Galectin 3 Revenue by Type
• 6.3 Galectin 3 Price by Type

7 Galectin 3 Segment Market Analysis (by Application)

• 7.1 Global Galectin 3 Consumption by Application
• 7.2 Global Galectin 3 Consumption Market Share by Application (2014-2019)

8 Galectin 3 Major Manufacturers Analysis

• 8.1 Angion Biomedica Corp
  • 8.1.1 Angion Biomedica Corp Galectin 3 Production Sites and Area Served
  • 8.1.2 Angion Biomedica Corp Product Introduction, Application and Specification
  • 8.1.3 Angion Biomedica Corp Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb Company
  • 8.2.1 Bristol-Myers Squibb Company Galectin 3 Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Company Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Galectin Therapeutics Inc
  • 8.3.1 Galectin Therapeutics Inc Galectin 3 Production Sites and Area Served
  • 8.3.2 Galectin Therapeutics Inc Product Introduction, Application and Specification
  • 8.3.3 Galectin Therapeutics Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 GlycoMimetics Inc
  • 8.4.1 GlycoMimetics Inc Galectin 3 Production Sites and Area Served
  • 8.4.2 GlycoMimetics Inc Product Introduction, Application and Specification
  • 8.4.3 GlycoMimetics Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 iTeos Therapeutics SA
  • 8.5.1 iTeos Therapeutics SA Galectin 3 Production Sites and Area Served
  • 8.5.2 iTeos Therapeutics SA Product Introduction, Application and Specification
  • 8.5.3 iTeos Therapeutics SA Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 MandalMed Inc
  • 8.6.1 MandalMed Inc Galectin 3 Production Sites and Area Served
  • 8.6.2 MandalMed Inc Product Introduction, Application and Specification
  • 8.6.3 MandalMed Inc Galectin 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Galectin 3 Market

• 9.1 Global Galectin 3 Market Trend Analysis
  • 9.1.1 Global Galectin 3 Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Galectin 3 Regional Market Trend
  • 9.2.1 North America Galectin 3 Forecast 2019-2025
  • 9.2.2 Europe Galectin 3 Forecast 2019-2025
  • 9.2.3 China Galectin 3 Forecast 2019-2025
  • 9.2.4 Japan Galectin 3 Forecast 2019-2025
  • 9.2.5 Southeast Asia Galectin 3 Forecast 2019-2025
  • 9.2.6 India Galectin 3 Forecast 2019-2025
• 9.3 Galectin 3 Market Trend (Product Type)
• 9.4 Galectin 3 Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Galectin 3 Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Galectin 3 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Galectin 3 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Galectin 3 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Galectin 3 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Galectin 3 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
GAL-300
GRMD-03
ANG-4021
KTI
Others

Segment by Application
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others